Call for worldwide withdrawal of tiotropium Respimat mist inhaler

Re: Call for worldwide withdrawal of tiotropium Respimat mist inhaler

28 November 2012

We share the concerns of Duncan Petty and Toby Hillman regarding the illustration of the Handihaler device. The authors did not see or approve the illustration as it was not included in the electronic proofs.

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; RB received funding from Boehringer Ingelheim to present at a symposium; no other relationships or activities that could appear to have influenced the submitted work.

Richard Beasley, Professor of Medicine

Sonal Singh, Yoon K Loke, Paul Enright, Curt D Furberg

Medical Research Institute of New Zealand, Private Bag 7902, Wellington 6242, NZ

Click to like: